精確搜索結(jié)果
- Products
- Applications and Industries
- 內(nèi)容類型
-
內(nèi)容類型
- Analysis Platform
-
產(chǎn)品
- 語言
-
語言
應(yīng)用的篩選條件
A Comparative Study of the Intact Mass, Subunit Mass, and Released Glycans of Two Rituximab Biosimilars Using High-Resolution LC/MS
- 文件出版號: 5994-1653EN
- 創(chuàng)建日期: 15 十月 2024
- 1 MB
The development and manufacturing of biosimilars require comparability studies with innovator biotherapeutic products.
- 文件出版號: 5994-1495EN
- 創(chuàng)建日期: 15 十月 2024
- 2 MB
LC/MS based characterization workflow of the GLP-1 therapeutic peptide liraglutide and its impurities using the 1290 Infinity II LC and 6545XT AdvanceBio LC/Q-TOF.
- 文件出版號: 5994-7727EN
- 創(chuàng)建日期: 25 九月 2024
- 3 MB
Ultimate flexibility for more informed decisions. One instrument and multiple workflows for biopharma.
- 文件出版號: 5991-7915EN
- 創(chuàng)建日期: 28 六月 2024
- 26 MB
In the current study, We present a solid method for peptide quantification using capillary LC-MS/MS, emphasizing three key analytical parameters: (1) limit of detection (LOD) and limit of quantification (LOQ), (2) linear range for multiple peptides,...
- 文件出版號: ASMS 2024 WP587
- 創(chuàng)建日期: 31 五月 2024
- 263 KB
Here we introduce the ability to?confirm?multiple?sequence?hypotheses?inside ExDViewer against a single TD mixture spectrum.
- 文件出版號: ASMS 2024 ThP025
- 創(chuàng)建日期: 31 五月 2024
- 962 KB
This application note utilizes the 1260 Infinity II Bio Prime LC and InfinityLab LC/MSD iQ for the confirmation of GLP-1 (Liraglutide) sample.
- 文件出版號: 5994-7415EN
- 創(chuàng)建日期: 01 五月 2024
- 1 MB
ASMS 2023 Poster - The present study describes a novel native 2D-SEC-MS-WCX-MS workflow that enables us to characterize and quantify aggregates and charge variants of mAb A through native mass spectrometry.
- 文件出版號: ASMS 2023 - MP 626
- 創(chuàng)建日期: 31 五月 2023
- 691 KB